staging
Routine staging includes clinical with gynecological examination, blood counts, routine chemistry including renal and liver function tests. MRI is superior to CT scan for tumor extension assessment and MRI is equal to CT scan for nodal assessment. MRI should be preferred to CT scan and include pelvic and abdominal imaging [III, A] . A thoracic CT scan may be included for metastasis assessment. SCC dosage in squamous cell carcinoma may be useful in patient follow-up if initially increased. Surgical pelvic and para-aortic nodal staging are optional and PET is under evaluation.
The most widely used classification is FIGO (Fédération 
FIGO stage IB1
There is no standard treatment. Options consist of surgery, external irradiation plus brachytherapy or combined radiosurgery [III, B] .
Standard surgery consists of radical hysterectomy, bilateral oophorectomy (optional) and pelvic lymphadenectomy. Conservative surgery can be proposed for a tumor with excellent prognostic factors. Combined radio-surgery usually consists of preoperative brachytherapy followed 6-8 weeks later by surgery. In patients treated with upfront surgery or preoperative brachytherapy followed by surgery presenting pelvic node involvement, standard treatment consists of complementary concomitant chemoradiation [I, B] . 
locoregional and metastatic recurrence
For most patients palliative chemotherapy is the standard option. Pelvic surgery (exenteration in most cases) and radiotherapy are an option in selected cases.
follow-up
Clinical with gynaecological examination including PAP smear (cave changes in patients irradiated) are performed every 3 months for the first 2 years, every 6 months for the next 3 years and yearly thereafter [III, C] . 
